Assessment of the Safety, Tolerability, and Pharmacokinetic of GMA106

Clinical trial NCT05054530 · COMPLETED

Trial details

NCT number: NCT05054530
Sponsor: Gmax Biopharm Australia Pty Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Overweight and Obesity

Start date: 2021-11-11
Primary completion: 2023-11-17
Enrollment: 73

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.